An increase in insulin sensitivity and basal beta-cell function in diabetic subjects treated with pioglitazone in a placebo-controlled randomized study.
AIMS: To investigate the effect of treatment with pioglitazone on beta-cell function and insulin sensitivity in Type 2 diabetes. METHODS: Thirty subjects with diet-controlled Type 2 diabetes were randomized to 3 months treatment with pioglitazone (n = 19) or placebo (n = 11). All subjects underwent...
Κύριοι συγγραφείς: | Wallace, T, Levy, J, Matthews, DR |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2004
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Pioglitazone increases whole body insulin sensitivity in obese, insulin-resistant rhesus monkeys.
ανά: Effie Tozzo, κ.ά.
Έκδοση: (2015-01-01) -
Pioglitazone and metformin.
ανά: Hill, N, κ.ά.
Έκδοση: (2007) -
The Insulin-Sensitizer Pioglitazone Remodels Adipose Tissue Phospholipids in Humans
ανά: Juan P. Palavicini, κ.ά.
Έκδοση: (2021-12-01) -
Pioglitazone/metformin - Viewpoint
ανά: Matthews, DR
Έκδοση: (2006) -
Application of structural model of glucose-insulin relations to assess beta-cell function and insulin sensitivity.
ανά: Turner, R, κ.ά.
Έκδοση: (1990)